Valuation: Manhattan Scientifics, Inc.

Market Cap 336K 299K 277K 251K 472K 31.67M 478K 3.32M 1.3M 16.64M 1.26M 1.23M 53.04M P/E 2022
-1.64x
P/E 2023 -1.25x
Enterprise Value 329K 293K 271K 245K 462K 31.01M 468K 3.25M 1.28M 16.3M 1.23M 1.21M 51.93M EV / Sales 2022
88,184,960x
EV / Sales 2023 -
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.01
5 years 0
Extreme 1.0E-6
0.03
10 years 0
Extreme 1.0E-6
0.05
Manager TitleAgeSince
Chief Executive Officer 74 2007-10-31
President 89 1997-12-31
Director TitleAgeSince
Chairman 89 -
Chairman 74 2007-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%-99.00% - - 559
-0.26%+3.26%+10.88%+118.06% 40.72B
+10.85%+11.47%-52.33%-31.57% 35.8B
+0.90%+6.40%-30.63%-33.42% 32.68B
+0.13%+3.41%+61.84%+163.85% 23.39B
+0.35%+8.75%-5.98%-0.44% 16.39B
+0.05%-0.60%-24.39%-27.49% 11.48B
-0.25%+2.05%+83.77%+138.76% 9.95B
+1.10%+8.45%-5.92%+74.65% 9.02B
-3.12%-11.58%-25.87%-12.44% 6.55B
Average -8.93%-9.69%+1.26%+43.33% 18.6B
Weighted average by Cap. +2.17%-1.22%-4.05%+43.37%

Financials

2022 2023
Net sales 0.05 0.04 0.04 0.04 0.07 4.72 0.07 0.49 0.19 2.48 0.19 0.18 7.9 -
Net income -2.73M -2.43M -2.25M -2.04M -3.84M -258M -3.89M -27M -10.6M -135M -10.24M -10.03M -432M -1.16M -1.04M -961K -870K -1.64M -110M -1.66M -11.52M -4.52M -57.79M -4.37M -4.28M -184M
Net Debt -65K -57.92K -53.63K -48.53K -91.43K -6.13M -92.51K -643K -252K -3.22M -244K -239K -10.27M -7K -6.24K -5.78K -5.23K -9.85K -661K -9.96K -69.24K -27.17K -347K -26.26K -25.71K -1.11M
Projected Income Statement - Annual - Manhattan Scientifics, Inc.
Logo Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Employees
1
Date Price Change Volume
26-10-19 US$0.000001 -99.00% 250
  1. Stock Market
  2. Stocks
  3. MHTX Stock